PTK2 and cancer: Matrine administration obviously decreased the phosphorylation levels of ERK1/2, MEK1/2, PI3K, Akt, mTOR, FAK, RhoA, VEGFR2 and Tie2 in vivo, and then accordingly retarded cancer associated signaling transduction.